Advances in Therapeutic Monitoring of Lithium in the Management of Bipolar Disorder

Since the mid-20th century, lithium continues to be prescribed as a first-line mood stabilizer for the management of bipolar disorder (BD). However, lithium has a very narrow therapeutic index, and it is crucial to carefully monitor lithium plasma levels as concentrations greater than 1.2 mmol/L are...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheikh, Mahsa, Qassem, Meha, Triantis, Iasonas F., Kyriacou, Panicos A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838674/
https://www.ncbi.nlm.nih.gov/pubmed/35161482
http://dx.doi.org/10.3390/s22030736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838674/
https://www.ncbi.nlm.nih.gov/pubmed/35161482
http://dx.doi.org/10.3390/s22030736

Ejemplares similares